Page last updated: 2024-10-27

flutamide and Bone Fractures

flutamide has been researched along with Bone Fractures in 2 studies

Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.

Research Excerpts

ExcerptRelevanceReference
"Men with prostate cancer who lacked radiographically detectable metastases were treated in a prospective trial of IAD."2.77Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer. ( Chen, S; Gambol, TE; Gulati, R; Hall, SP; Higano, CS; Jiang, PY; Kuo, KF; Pitzel, P; Yu, EY, 2012)
"Four patients suffered bone fractures, none pathological."1.31A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men. ( Baba, S; Egawa, S; Kuwao, S; Matsumoto, K; Mizoguchi, H; Takashima, R, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, EY1
Kuo, KF1
Gulati, R1
Chen, S1
Gambol, TE1
Hall, SP1
Jiang, PY1
Pitzel, P1
Higano, CS1
Egawa, S1
Takashima, R1
Matsumoto, K1
Mizoguchi, H1
Kuwao, S1
Baba, S1

Trials

1 trial available for flutamide and Bone Fractures

ArticleYear
Long-term dynamics of bone mineral density during intermittent androgen deprivation for men with nonmetastatic, hormone-sensitive prostate cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, May-20, Volume: 30, Issue:15

    Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormon

2012

Other Studies

1 other study available for flutamide and Bone Fractures

ArticleYear
A pilot study of intermittent androgen ablation in advanced prostate cancer in Japanese men.
    Japanese journal of clinical oncology, 2000, Volume: 30, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alkaline Phosphatase; Androgen Antagonists; Antineoplastic

2000